Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients

NCT04452929 is registered in ClinicalTrials.gov with Danish Headache Center as lead sponsor.

NCT NCT04452929
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04452929 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients
Lead sponsor
Danish Headache Center
Phase
Not applicable
Overall status
Unknown status
Start date
July 22, 2020
Completion date
July 31, 2022
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine, migraine with aura, migraine without aura